zantac, drank 150 mg/10 ml
glaxosmithkline b.v. - ranitidinehydrochloride samenstelling overeenkomend met; ranitidine; - drank - ranitidine
zantac 50 mg/2 ml inj. opl. i.v./i.m. amp.
glaxosmithkline pharmaceuticals sa-nv - ranitidinehydrochloride 28 mg/ml - eq. ranitidine 25 mg/ml - oplossing voor injectie - 50 mg/2 ml - ranitidinehydrochloride 28 mg/ml - ranitidine
zantac 150 mg/10 ml siroop
glaxosmithkline pharmaceuticals sa-nv - ranitidinehydrochloride 16,8 mg/ml - eq. ranitidine 15 mg/ml - siroop - 150 mg/10 ml - ranitidinehydrochloride 16.8 mg/ml - ranitidine
acidine 75 mg bruistabl.
eg sa-nv - ranitidinehydrochloride 83,7 mg - eq. ranitidine 75 mg - bruistablet - 75 mg - ranitidinehydrochloride 83.7 mg - ranitidine
ranitidine eg 150 mg bruistabl.
eg sa-nv - ranitidinehydrochloride 167,4 mg - eq. ranitidine 150 mg - bruistablet - ranitidine
ranitidine eg 300 mg bruistabl.
eg sa-nv - ranitidinehydrochloride 334,8 mg - eq. ranitidine 300 mg - bruistablet - ranitidine
ranitidine mylan 75 mg filmomh. tabl.
viatris gx bv-srl - ranitidinehydrochloride 83,75 mg - eq. ranitidine 75 mg - filmomhulde tablet - ranitidine
zantac 75 bruis, bruistabletten 75 mg
omega pharma nederland b.v. - ranitidinehydrochloride samenstelling overeenkomend met; ranitidine; - bruistablet - ranitidine
zantac 75, tabletten 75 mg
omega pharma nederland b.v. kralingseweg 201 3062 ce rotterdam - ranitidinehydrochloride samenstelling overeenkomend met ; ; ranitidine - tablet - cellulose, microkristallijn (e 460) ; glyceroltriacetaat (e 1518) ; hypromellose (e 464) ; ijzeroxide rood (e 172) ; magnesiumstearaat (e 470b) ; titaandioxide (e 171), - ranitidine
zantac 150 mg/10 ml, drank
medcor pharmaceuticals b.v. - ranitidinehydrochloride samenstelling overeenkomend met; ranitidine; - drank - ranitidine